China Resources Sanjiu Medical & Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
China Resources Sanjiu Medical & Pharmaceutical Co Ltd cash flow-to-debt ratio. China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Cash Flow-to-Debt Ratio of 0.13x as of December 2025, meaning its operating cash flow of CN¥2.60 Billion could theoretically repay 0% of its total liabilities (CN¥20.03 Billion) in one year. Check China Resources Sanjiu Medical & Pharmac total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2025)
Cash flow-to-debt ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 1999 to 2025. Historical debt coverage capacity for China Resources Sanjiu Medical & Pharmaceutical Co Ltd across 27 annual periods. Check China Resources Sanjiu Medical & Pharmac earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (1999–2025)
China Resources Sanjiu Medical & Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 1999 to 2025. Year-by-year debt coverage analysis for China Resources Sanjiu Medical & Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see China Resources Sanjiu Medical & Pharmac (000999) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | CN¥5.51 Billion | CN¥20.03 Billion | ▼ -7.3% |
| 2024 | 0.30x | CN¥4.40 Billion | CN¥14.83 Billion | ▲ +12.5% |
| 2023 | 0.26x | CN¥4.19 Billion | CN¥15.89 Billion | ▼ -15.8% |
| 2022 | 0.31x | CN¥3.01 Billion | CN¥9.59 Billion | ▲ +45.8% |
| 2021 | 0.21x | CN¥1.88 Billion | CN¥8.77 Billion | ▼ -21.7% |
| 2020 | 0.27x | CN¥2.22 Billion | CN¥8.10 Billion | ▲ +15.9% |
| 2019 | 0.24x | CN¥1.97 Billion | CN¥8.32 Billion | ▼ -15.0% |
| 2018 | 0.28x | CN¥1.91 Billion | CN¥6.86 Billion | ▲ +5.8% |
| 2017 | 0.26x | CN¥1.60 Billion | CN¥6.07 Billion | ▼ -8.6% |
| 2016 | 0.29x | CN¥1.39 Billion | CN¥4.83 Billion | ▼ -0.6% |
| 2015 | 0.29x | CN¥1.26 Billion | CN¥4.35 Billion | ▼ -10.1% |
| 2014 | 0.32x | CN¥1.18 Billion | CN¥3.67 Billion | ▼ -16.9% |
| 2013 | 0.39x | CN¥1.47 Billion | CN¥3.78 Billion | ▼ -1.7% |
| 2012 | 0.40x | CN¥1.21 Billion | CN¥3.07 Billion | ▲ +13.7% |
| 2011 | 0.35x | CN¥954.90 Million | CN¥2.75 Billion | ▼ -23.9% |
| 2010 | 0.46x | CN¥848.28 Million | CN¥1.86 Billion | ▼ -10.3% |
| 2009 | 0.51x | CN¥855.05 Million | CN¥1.68 Billion | ▼ -22.4% |
| 2008 | 0.66x | CN¥1.12 Billion | CN¥1.70 Billion | ▲ +439.8% |
| 2007 | 0.12x | CN¥605.30 Million | CN¥4.98 Billion | ▲ +29.1% |
| 2006 | 0.09x | CN¥425.51 Million | CN¥4.52 Billion | ▲ +1818.8% |
| 2005 | 0.00x | CN¥22.83 Million | CN¥4.65 Billion | ▲ +103.3% |
| 2004 | -0.15x | CN¥-719.63 Million | CN¥4.89 Billion | ▼ -2849.2% |
| 2003 | 0.01x | CN¥28.09 Million | CN¥5.25 Billion | ▼ -95.8% |
| 2002 | 0.13x | CN¥496.12 Million | CN¥3.88 Billion | ▲ +204.1% |
| 2001 | 0.04x | CN¥153.44 Million | CN¥3.65 Billion | ▼ -55.7% |
| 2000 | 0.09x | CN¥266.86 Million | CN¥2.81 Billion | ▼ -27.2% |
| 1999 | 0.13x | CN¥120.63 Million | CN¥925.96 Million | — |